Severe acute interstitial lung disease induced by crizotinib therapy in a patient with c-Met amplification non-small cell lung cancer

Chin Med J (Engl). 2014;127(8):1600.

Authors

Youxin Ji¹, Zhongfa Zhang², Keke Nie², Ketao Lan², Chuanxin Geng², Shichao Liu², Ling Zhang², Zongchun Zhang², Lei Sun², Xiao Zou²

Affiliations

¹ Department of Oncology, Qingdao Central Hospital, Second Affiliated Hospital of Qingdao University, Qingdao, Shandong 266042, China. Email: [email protected].
² Department of Oncology, Qingdao Central Hospital, Second Affiliated Hospital of Qingdao University, Qingdao, Shandong 266042, China.

PMID: 24762619

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Carcinoma, Non-Small-Cell Lung / drug therapy*
Crizotinib
Humans
Lung Diseases, Interstitial / chemically induced*
Lung Diseases, Interstitial / diagnosis*
Male
Middle Aged
Protein Kinase Inhibitors / adverse effects*
Protein Kinase Inhibitors / therapeutic use*
Pyrazoles / adverse effects*
Pyrazoles / therapeutic use*
Pyridines / adverse effects*
Pyridines / therapeutic use*

Substances

Protein Kinase Inhibitors
Pyrazoles
Pyridines
Crizotinib